Saturday, August 1, 2026

Kim Yo Jong Urges U.S. to End Hostile Policy, Warns North Korea Will Not Stand Idle

Kim Yo Jong condemns the U.S. deployment of the USS Carl Vinson, asserting North Korea's resolve to strengthen its nuclear deterrence.

10CM, Sunwoo Jung A, and Car, the Garden Begin New Journey with CAM

10CM, Sunwoo Jung A, and Car, the Garden join CAM, aiming to enhance their music careers and connect with fans through new projects.

North Korea’s Missile Fizzles Out, Exploding Over the Sea

North Korea launched a ballistic missile into the East Sea early on the morning of the 26th, but it failed to complete a routine flight.

Health

Enhanced Recovery Protocol Speeds Recovery After Brain Aneurysm Surgery, Study Finds

Enhanced Recovery After Surgery (ERAS) can significantly improve recovery speed for patients undergoing brain aneurysm surgery.

Celltrion’s Omlyclo Gains Traction in Italy, Reinforcing Direct Sales Strategy as Growth Expected to Accelerate

Celltrion expands its biosimilar supply in Italy, enhancing its competitiveness in the European pharmaceutical market.

CG Bio Treats First U.S. Patient With Bone Graft Substitute, Advances FDA Approval

Sigibio accelerates clinical development for FDA approval after the first U.S. patient procedure with its next-gen bone substitute, Novosis Putty.

Is Winuf IV the Future of Nutritional IV Therapy? A Deep Dive into Omega-3’s Role in Healing

JW Pharmaceutical introduces clinical applications of omega-3 based nutrient infusion Winuf Inj. to medical professionals.

Next-Gen Surface Induction Radiation Therapy: A Game Changer for Breast Cancer Patients?

Breast cancer patients may soon avoid discomfort from tattoos or markings during radiation therapy.
Latest

Unlocking the Mystery: How Anti-CTLA-4 Boosts B Cell Response Against Brain Tumors

Researchers reveal that B cells, not just T cells, are crucial for the success of immune checkpoint inhibitors in treating glioblastoma.

“We Treat Patients’ Lives, Not Just Cancer” — The Future of Cancer Care Led by a Breast Cancer Pioneer [K-Medical Report]

A compassionate approach to cancer treatment, emphasizing emotional support and tailored care, leads to high survival rates and patient satisfaction.

South Korea Eases Phase 3 Trial Requirements for Biosimilars Following U.S. and EU… Early Data Becomes Key Battleground

South Korea's MFDS eases Phase 3 trial requirements for biosimilars, aligning with global trends, enhancing early comparability importance.

HLB’s Liver Cancer Drug: FDA’s VAI Conclusion Sparks Hope for Approval

HLB's Rivoceranib facility passed FDA inspection, receiving VAI classification, moving towards new liver cancer drug approval.

How Salidroside from Korean Ginseng Can Combat Insulin Resistance and Prevent Diabetes

Research reveals salicin from tianma improves insulin resistance, aiding diabetes prevention and intestinal health restoration.

Smoking Raises Fatty Liver Risk by Up to 1.5 Times Among Young Adults

Young adult smokers face a higher risk of fatty liver disease, with significant findings on its impact regardless of obesity or alcohol consumption.

[Exclusive] HLB’s Liver Cancer Drug Clears Camrelizumab CMC Review, but Hengrui Manufacturing Facility Becomes New Hurdle

HLB's liver cancer drug approval faces delays due to FDA findings at Hengrui's facility, despite resolution of previous issues.

U.S. pharmaceutical companies’ China clinical trial security probe to conclude this week… Could biotech rivalry intensify?

A U.S. investigation into pharmaceutical trials in China may reshape global biotech strategies, impacting South Korean firms.

“Automation Alone Isn’t Enough”: Hugel Executive Highlights the Company’s Quality-First Manufacturing Strategy

Hugel's Geodu facility expands botulinum toxin production while prioritizing consistent quality over volume, ensuring global market compliance.

Shaperon Secures South Korean Patent for Pulmonary Fibrosis Drug Candidate NuPulin

Shaperon secures a South Korean patent for NuPulin, an oral drug for idiopathic pulmonary fibrosis, showing promising preclinical results.

How ATF4 and CHOP Proteins Decide Cell Fate: Key Discoveries in Stress Response

Researchers identified how genetic mechanisms determine cell survival or death under stress, revealing insights for disease treatment.

How Celltrion’s Omlyclo Achieved 16% Market Share in Europe: A Game-Changer for Biologics

Celltrion's biosimilars gain market share in Europe, with Omlyclo leading in Spain and Vegzelma maintaining strong presence amid competition.

Metabolic Surgery for Obese Seniors: A Safe Solution for Diabetes and Hypertension?

A study shows metabolic obesity surgery is safe for patients over 55, improving diabetes and other metabolic diseases effectively.

Belvarafenib: The Promising New Targeted Cancer Drug for NRAS Mutant Melanoma

Hanmi Pharmaceutical presents Belvarafenib's phase 2 trial for NRAS mutant melanoma at KCA 2026, targeting unmet medical needs.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.